We are recruiting for 3 PhD student positions, investigating different aspects of the lung cancer tumour microenvironment, within the context of an exciting EU collaboration! Great facilities & great teams! 🔬 werkenbij.amsterdamumc.org/en/vacatures/r… Apply before 6th July!

Our Mol. Cell Biology and Immunology Lab department is #hiring 3 #PhD students to study the lung cancer tumor microenvironment in the context of a EU Horizon Mission cancer consortium. Immunometabolism, glycobiology (Yvette van Kooyk), T cell function (Febe van Maldegem),... pick your favorite and apply ⬇️

SPACETIME project starts today! 15 partners from 7 different European countries will work on spatially decoding lung cancer 🫁🔬. Today, we honor the World Lung Cancer Day and commit to do our best for patients! #SPACETIME #WorldLungCancerDay #EUfunded #HaDEA #EUMissionCancer🇪🇺

SPACETIME brings together brilliant minds from Europe to spatiotemporally map the complex tumour-host coevolution in lung cancer, with the aim to understand how mechanisms of immune suppression develop and how these can be targeted therapeutically. #WorldLungCancerDay2024

"Lung cancer is one of the hardest types of cancer to treat, so working out how to harness the immune system to better target tumours is so important." Read about the new work from Megan Cole, Julian Downward, Febe van Maldegem and more ⤵️ crick.ac.uk/news-and-repor…

In our new paper just out in Science Advances we investigate mechanisms that may be limiting responses of KRAS mutant lung cancer to KRAS inhibitors and immunotherapy. science.org/doi/10.1126/sc…

ddw-online.com/tregs-block-im…